Stories of Interest in 2012
As we bring 2012 to a close, we're looking back at a few of the interesting events that took place. It was a challenge to whittle this down to a…
As we bring 2012 to a close, we're looking back at a few of the interesting events that took place. It was a challenge to whittle this down to a…
Consider the following situation: You are out-licensing an innovative asset in a niche therapeutic area It is a first-in-class molecule It has successfully demonstrated efficacy in two international Phase…
As we've done in the past, we've tabulated the countries of origin from the stack of business card collected at BIO Europe 2012. Our "rules" for this analysis are simple.…
We’ve returned from BIO Europe 2012 in Hamburg with a stack of business cards, pages of meeting notes, prioritized follow ups, and some great memories. We managed to completely fill…
We spent a few days in Chicago attending the AAPS Convention. As usual, it was jammed with excellent science, tons of exhibitors, and great opportunities to catch up with old…
Next week, Lacerta Bio will be at the AAPS Annual Meeting in Chicago. If you have plans to attend, drop us a note! To follow the action on Twitter, use…
Lacerta Bio is pleased to announce our attendance at the upcoming BIO-Europe 2012 conference in Hamburg, Germany. In our view, the Fall version of BIO-Europe is the premier partnering…
As with BIO 2011, the bulk of our time was spent in the One-on-One Partnering sessions. More general reviews are found here, here, and here. As usual, BIO put on…
Yesterday, we responded on LinkedIn to the following note: THis is our first BIO conference in June and want to make it a great one. Any hints or helpful suggestions…
Lacerta Bio has returned to cold, windy New York following a solid week in sunny, warm San Francisco. We blogged about last year's JP Morgan Healthcare conference here . For…